Tangier Disease Clinical Trial
Verified date | June 2013 |
Source | Isfahan University of Medical Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | Iran: Ethics Committee |
Study type | Interventional |
The investigators aimed to determine the effects of HP diet on CVD risk factors among overweight and obese children.
Status | Completed |
Enrollment | 50 |
Est. completion date | September 2012 |
Est. primary completion date | December 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 6 Years to 11 Years |
Eligibility |
Inclusion Criteria: - BMI > 85th age of 6-11 years - no history of chronic diseases - no taken medications Exclusion Criteria: - do not prescribe their diet - mental retardation |
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Isfahan University of Medical Sciences | Isfahan |
Lead Sponsor | Collaborator |
---|---|
Isfahan University of Medical Sciences |
Iran, Islamic Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the amount of weight reduction in two dietary groups | weight reduction (kg) | 10 weeks | Yes |
Secondary | LDL (mg/ml) | 10 weeks | Yes | |
Secondary | HDL (mg/ml) | 10 weeks | Yes | |
Secondary | fasting blood glucose | 10 weeks | Yes | |
Secondary | total cholesterol (mg/dl) | 10 weeks | Yes | |
Secondary | blood pressure | 10 weeks | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01886495 -
Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese Children
|
Phase 3 | |
Suspended |
NCT01782027 -
Mendelian Reverse Cholesterol Transport Study
|
N/A | |
Completed |
NCT00005188 -
Quantitative Genetic Analysis of Lipid Research Clinic Family Data
|
N/A | |
Completed |
NCT01763528 -
High Protein Weight Loss Diet, High Sensitivity C-Reactive Protein and Cardiovascular Risks Among Obese Women
|
Phase 3 |